How do we maintain a dual inventory of room temperature stored platelets with cold‐stored platelets?
Transfusion · 2025-07 · 65 (7) · 1218-1222
DOI: 10.1111/trf.18289 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, online erschienen am 25.05.2025. Verfasst von Claudia S Cohn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, M-Health Fairview, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Blood Preservation, Blood Platelets, Platelet Transfusion. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
There has been renewed interest in cold‐stored platelets (CSPs) for the management of bleeding patients. CSPs might offer advantages over conventional room temperature stored platelet units (RTP), such as a lower risk of bacterial growth during storage, a longer shelf lf life, and possibly improved hemostatic effectiveness. However, CSPs have reduced in vivo survival compared to RTP. In 2023, the FDA issued guidance allowing 14‐day storage of CSPs for the treatment of active bleeding when conventional platelets are not available or their use is not practical. This How Do We describes various scenarios of CSP use, followed by the authors' assessment regarding consistency with FDA recommendations.
Methods
The authors contributed scenarios that reflected their institutions' unique settings or more generalized scenarios common to other centers. The authors offered their interpretation of the guidance for each specific situation.
Results
Seven scenarios are provided that demonstrate potentially appropriate or clearly inappropriate CSP use across a variety of settings. The authors' interpretations aim to help hospital transfusion services develop standard operating procedures (SOPs) that are suitable for their own unique circumstances.
Discussion
Each hospital has a unique setting and set of conditions that influence CSP use. This How Do We provides the authors' assessments regarding how CSPs may be used in certain scenarios; however, this is not a guide and does not offer official recommendations. Every center must develop SOPs that account for usage patterns and inventory constraints specific to its own environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, M-Health Fairview, Minneapolis, Minnesota, USA.
- Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
- Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
- Vitalant, Clinical Services, Northeast Division, Pittsburgh, Pennsylvania, USA.
- Trauma and Transfusion Medicine Research Center, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- American Red Cross, Biomedical Services Headquarters, Washington, District of Columbia, USA.
ORCID-Profile: Claudia S Cohn, Nancy M Dunbar, Alesia Kaplan, Philip C Spinella, Pampee P Young, Alyssa Ziman
Zitieren
APA
Cohn, C. S., Dunbar, N. M., Kaplan, A., Spinella, P. C., Young, P. P., & Ziman, A. (2025). How do we maintain a dual inventory of room temperature stored platelets with cold‐stored platelets?. Transfusion, 65(7), 1218-1222. https://doi.org/10.1111/trf.18289
Vancouver
Cohn CS, Dunbar NM, Kaplan A, Spinella PC, Young PP, Ziman A. How do we maintain a dual inventory of room temperature stored platelets with cold‐stored platelets?. Transfusion. 2025;65(7):1218-1222. doi:10.1111/trf.18289
BibTeX
@article{Cohn2025,
author = {Cohn, Claudia S and Dunbar, Nancy M and Kaplan, Alesia and Spinella, Philip C and Young, Pampee P and Ziman, Alyssa},
title = {How do we maintain a dual inventory of room temperature stored platelets with cold‐stored platelets?},
journal = {Transfusion},
year = {2025},
volume = {65},
number = {7},
pages = {1218--1222},
doi = {10.1111/trf.18289}
}
EUVIMED